Literature DB >> 10103018

Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cells.

Y Hiraki1, K Mitsui, N Endo, K Takahashi, T Hayami, H Inoue, C Shukunami, K Tokunaga, T Kono, M Yamada, H E Takahashi, J Kondo.   

Abstract

Bovine chondromodulin-I (ChM-I) purified from fetal cartilage stimulated the matrix synthesis of chondrocytes, and inhibited the growth of vascular endothelial cells in vitro. The human counterpart of this bovine growth regulating factor has not been identified. We report here the cloning of human ChM-I precursor cDNA and its functional expression in Chinese hamster ovary (CHO) cells. We first identified a genomic DNA fragment which encoded the N-terminus of the ChM-I precursor, and then isolated human ChM-I cDNA from chondrosarcoma tissue by PCR. The deduced amino acid sequence revealed that mature human ChM-I consists of 120 amino acids. In total, 16 amino acid residues were substituted in the human sequence, compared to the bovine counterpart. Almost of all the substitutions were found in the N-terminal hydrophilic domain. In the C-terminal hydrophobic domain (from Phe42 to Val120), the amino acid sequence was identical except for Tyr90, indicating a functional significance of the domain. Northern blotting and in situ hybridization indicated a specific expression of ChM-I mRNA in cartilage. We also successfully determined the cartilage-specific localization of ChM-I protein, using a specific antibody against recombinant human ChM-I. Multiple transfection of the precursor cDNA into CHO cells enabled us to isolate the mature form of human ChM-I from the culture supernatant. Purified recombinant human ChM-I stimulated proteoglycan synthesis in cultured chondrocytes. In contrast, it inhibited the tube morphogenesis of cultured vascular endothelial cells in vitro and angiogenesis in chick chorioallantoic membrane in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10103018     DOI: 10.1046/j.1432-1327.1999.00227.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  17 in total

1.  A functional role of the glycosylated N-terminal domain of chondromodulin-I.

Authors:  Jun Kondo; Hiroyuki Shibata; Shigenori Miura; Akira Yamakawa; Koji Sato; Yoshiki Higuchi; Chisa Shukunami; Yuji Hiraki
Journal:  J Bone Miner Metab       Date:  2010-05-27       Impact factor: 2.626

2.  Cartilage-specific matrix protein chondromodulin-I is associated with chondroid formation in salivary pleomorphic adenomas: immunohistochemical analysis.

Authors:  K Kusafuka; Y Hiraki; C Shukunami; A Yamaguchi; T Kayano; T Takemura
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

3.  Immunohistochemical evaluation of cartilage-derived morphogenic protein-1 and -2 in normal human salivary glands and pleomorphic adenomas.

Authors:  Kimihide Kusafuka; Franck P Luyten; Raymond De Bondt; Yuji Hiraki; Chisa Shukunami; Teruo Kayano; Tamiko Takemura
Journal:  Virchows Arch       Date:  2003-04-18       Impact factor: 4.064

Review 4.  New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders.

Authors:  S C Ballara; J M Miotla; E M Paleolog
Journal:  Int J Exp Pathol       Date:  1999-10       Impact factor: 1.925

Review 5.  The essential anti-angiogenic strategies in cartilage engineering and osteoarthritic cartilage repair.

Authors:  Song Chen; Yixuan Amy Pei; Ming Pei
Journal:  Cell Mol Life Sci       Date:  2022-01-14       Impact factor: 9.261

6.  Benzene metabolite hydroquinone up-regulates chondromodulin-I and inhibits tube formation in human bone marrow endothelial cells.

Authors:  Hongfei Zhou; Jadwiga K Kepa; David Siegel; Shigenori Miura; Yuji Hiraki; David Ross
Journal:  Mol Pharmacol       Date:  2009-06-12       Impact factor: 4.436

7.  Expression and localization of cartilage-specific matrix protein chondromodulin-I mRNA in salivary pleomorphic adenomas.

Authors:  Kimihide Kusafuka; Keisuke Nakano; Yuji Hiraki; Chisa Shukunami; Hitoshi Nagatsuka; Noriyuki Nagai; Tamiko Takemura; Yutaku Sakaguchi; Kazuichi Okazaki; Michi Kusafuka; Hiroko Hisha; Susumu Ikehara
Journal:  Virchows Arch       Date:  2004-11-11       Impact factor: 4.064

8.  Synthetic disulfide-bridged cyclic peptides mimic the anti-angiogenic actions of chondromodulin-I.

Authors:  Shigenori Miura; Jun Kondo; Toru Kawakami; Chisa Shukunami; Saburo Aimoto; Hideyuki Tanaka; Yuji Hiraki
Journal:  Cancer Sci       Date:  2012-04-27       Impact factor: 6.716

9.  Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells.

Authors:  U Thiel; S Pirson; C Müller-Spahn; H Conrad; D H Busch; H Bernhard; S Burdach; G H S Richter
Journal:  Br J Cancer       Date:  2011-03-15       Impact factor: 7.640

10.  Chondromodulin-1 directly suppresses growth of human cancer cells.

Authors:  Hisashi Mera; Hiroyuki Kawashima; Tatsuya Yoshizawa; Osamu Ishibashi; Md Moksed Ali; Tadashi Hayami; Hiroshi Kitahara; Hiroshi Yamagiwa; Naoki Kondo; Akira Ogose; Naoto Endo; Hiroyuki Kawashima
Journal:  BMC Cancer       Date:  2009-05-31       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.